Author contributions
K.L.C and S.M.A wrote all aspects of this manuscript.
Disclosure statement
S.M.A receives research funding from: Bristol-Myers Squibb, Seattle Genetics, Affimed Therapeutics, Regeneron, Trillium Therapeutics, AI Therapeutics, ADC Therapeutics. All remaining authors declare no competing conflict-of-interests.